
Multi-Node PI3K Inhibition for Cancer: Optimizing Efficacy and Safety While Broadening the Patient Population
Two alternative approaches to drugging one of the most frequently dysregulated pathways in cancer have recently been gathering momentum in clinical development. The post Multi-Node PI3K Inhibition for Cancer: Optimizing Efficacy and Safety While Broadening the Patient Population appeared first on MedCity News.